Xue GF - Search Results

1

A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat.

Han L, Hölscher C, Xue GF, Li G, Li D. Han L, et al. Among authors: xue gf. Neuroreport. 2016 Jan 6;27(1):23-32. doi: 10.1097/WNR.0000000000000490. Neuroreport. 2016. PMID: 26555034

2

Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease.

Ji C, Xue GF, Li G, Li D, Hölscher C. Ji C, et al. Among authors: xue gf. Rev Neurosci. 2016 Jan;27(1):61-70. doi: 10.1515/revneuro-2015-0021. Rev Neurosci. 2016. PMID: 26351802 Free article. Review.

3

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.

Ji C, Xue GF, Lijun C, Feng P, Li D, Li L, Li G, Hölscher C. Ji C, et al. Among authors: xue gf. Brain Res. 2016 Mar 1;1634:1-11. doi: 10.1016/j.brainres.2015.09.035. Epub 2015 Oct 11. Brain Res. 2016. PMID: 26453833 Free article.

4

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.

Cao L, Li D, Feng P, Li L, Xue GF, Li G, Hölscher C. Cao L, et al. Among authors: xue gf. Neuroreport. 2016 Apr 13;27(6):384-91. doi: 10.1097/WNR.0000000000000548. Neuroreport. 2016. PMID: 26918675

5

A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.

Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C. Yuan Z, et al. Eur J Pharmacol. 2017 Oct 5;812:82-90. doi: 10.1016/j.ejphar.2017.06.029. Epub 2017 Jun 27. Eur J Pharmacol. 2017. PMID: 28666800

6

Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.

Feng P, Zhang X, Li D, Ji C, Yuan Z, Wang R, Xue G, Li G, Hölscher C. Feng P, et al. Neuropharmacology. 2018 May 1;133:385-394. doi: 10.1016/j.neuropharm.2018.02.012. Epub 2018 Feb 17. Neuropharmacology. 2018. PMID: 29462693 Free article.

7

Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus.

Wang RF, Xue GF, Hölscher C, Tian MJ, Feng P, Zheng JY, Li DF. Wang RF, et al. Among authors: xue gf. Epilepsy Res. 2018 May;142:45-52. doi: 10.1016/j.eplepsyres.2018.03.009. Epub 2018 Mar 9. Epilepsy Res. 2018. PMID: 29549796

8

The novel GLP-1/GIP dual receptor agonist DA3-CH is neuroprotective in the pilocarpine-induced epileptogenesis rat model.

Tian MJ, Wang RF, Hölscher C, Mi RL, Yuan ZY, Li DF, Xue GF. Tian MJ, et al. Among authors: xue gf. Epilepsy Res. 2019 Aug;154:97-106. doi: 10.1016/j.eplepsyres.2019.05.008. Epub 2019 May 8. Epilepsy Res. 2019. PMID: 31121474

9

The novel GLP-1/GIP dual agonist DA3-CH is more effective than liraglutide in reducing endoplasmic reticulum stress in diabetic rats with cerebral ischemia-reperfusion injury.

Bai B, Li D, Xue G, Feng P, Wang M, Han Y, Wang Y, Hölscher C. Bai B, et al. Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):333-343. doi: 10.1016/j.numecd.2020.09.002. Epub 2020 Sep 12. Nutr Metab Cardiovasc Dis. 2021. PMID: 33500109

10

The GLP-1/GIP dual-receptor agonist DA5-CH inhibits the NF-κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP-1 single-receptor agonist NLY01.

Lv M, Xue G, Cheng H, Meng P, Lian X, Hölscher C, Li D. Lv M, et al. Brain Behav. 2021 Aug;11(8):e2231. doi: 10.1002/brb3.2231. Epub 2021 Jun 14. Brain Behav. 2021. PMID: 34125470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters